Somatostatin receptor 1 and 5 double knockout mice mimic neurochemical changes of Huntington's disease transgenic mice.

Selective degeneration of medium spiny neurons and preservation of medium sized aspiny interneurons in striatum has been implicated in excitotoxicity and pathophysiology of Huntington's disease (HD). However, the molecular mechanism for the selective sparing of medium sized aspiny neurons and v...

Full description

Bibliographic Details
Main Authors: Padmesh S Rajput, Geetanjali Kharmate, Michael Norman, Shi-He Liu, Bhagavatula R Sastry, Charles F Brunicardi, Ujendra Kumar
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2011-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC3166321?pdf=render
id doaj-3047c79056214ffda57b24791bc9d4c7
record_format Article
spelling doaj-3047c79056214ffda57b24791bc9d4c72020-11-25T00:08:36ZengPublic Library of Science (PLoS)PLoS ONE1932-62032011-01-0169e2446710.1371/journal.pone.0024467Somatostatin receptor 1 and 5 double knockout mice mimic neurochemical changes of Huntington's disease transgenic mice.Padmesh S RajputGeetanjali KharmateMichael NormanShi-He LiuBhagavatula R SastryCharles F BrunicardiUjendra KumarSelective degeneration of medium spiny neurons and preservation of medium sized aspiny interneurons in striatum has been implicated in excitotoxicity and pathophysiology of Huntington's disease (HD). However, the molecular mechanism for the selective sparing of medium sized aspiny neurons and vulnerability of projection neurons is still elusive. The pathological characteristic of HD is an extensive reduction of the striatal mass, affecting caudate putamen. Somatostatin (SST) positive neurons are selectively spared in HD and Quinolinic acid/N-methyl-D-aspartic acid induced excitotoxicity, mimic the model of HD. SST plays neuroprotective role in excitotoxicity and the biological effects of SST are mediated by five somatostatin receptor subtypes (SSTR1-5).To delineate subtype selective biological responses we have here investigated changes in SSTR1 and 5 double knockout mice brain and compared with HD transgenic mouse model (R6/2). Our study revealed significant loss of dopamine and cAMP regulated phosphoprotein of 32 kDa (DARPP-32) and comparable changes in SST, N-methyl-D-aspartic acid receptors subtypes, calbindin and brain nitric oxide synthase expression as well as in key signaling proteins including calpain, phospho-extracellular-signal-regulated kinases1/2, synapsin-IIa, protein kinase C-α and calcineurin in SSTR1/5(-/-) and R6/2 mice. Conversely, the expression of somatostatin receptor subtypes, enkephalin and phosphatidylinositol 3-kinases were strain specific. SSTR1/5 appears to be important in regulating NMDARs, DARPP-32 and signaling molecules in similar fashion as seen in HD transgenic mice.This is the first comprehensive description of disease related changes upon ablation of G- protein coupled receptor gene. Our results indicate that SST and SSTRs might play an important role in regulation of neurodegeneration and targeting this pathway can provide a novel insight in understanding the pathophysiology of Huntington's disease.http://europepmc.org/articles/PMC3166321?pdf=render
collection DOAJ
language English
format Article
sources DOAJ
author Padmesh S Rajput
Geetanjali Kharmate
Michael Norman
Shi-He Liu
Bhagavatula R Sastry
Charles F Brunicardi
Ujendra Kumar
spellingShingle Padmesh S Rajput
Geetanjali Kharmate
Michael Norman
Shi-He Liu
Bhagavatula R Sastry
Charles F Brunicardi
Ujendra Kumar
Somatostatin receptor 1 and 5 double knockout mice mimic neurochemical changes of Huntington's disease transgenic mice.
PLoS ONE
author_facet Padmesh S Rajput
Geetanjali Kharmate
Michael Norman
Shi-He Liu
Bhagavatula R Sastry
Charles F Brunicardi
Ujendra Kumar
author_sort Padmesh S Rajput
title Somatostatin receptor 1 and 5 double knockout mice mimic neurochemical changes of Huntington's disease transgenic mice.
title_short Somatostatin receptor 1 and 5 double knockout mice mimic neurochemical changes of Huntington's disease transgenic mice.
title_full Somatostatin receptor 1 and 5 double knockout mice mimic neurochemical changes of Huntington's disease transgenic mice.
title_fullStr Somatostatin receptor 1 and 5 double knockout mice mimic neurochemical changes of Huntington's disease transgenic mice.
title_full_unstemmed Somatostatin receptor 1 and 5 double knockout mice mimic neurochemical changes of Huntington's disease transgenic mice.
title_sort somatostatin receptor 1 and 5 double knockout mice mimic neurochemical changes of huntington's disease transgenic mice.
publisher Public Library of Science (PLoS)
series PLoS ONE
issn 1932-6203
publishDate 2011-01-01
description Selective degeneration of medium spiny neurons and preservation of medium sized aspiny interneurons in striatum has been implicated in excitotoxicity and pathophysiology of Huntington's disease (HD). However, the molecular mechanism for the selective sparing of medium sized aspiny neurons and vulnerability of projection neurons is still elusive. The pathological characteristic of HD is an extensive reduction of the striatal mass, affecting caudate putamen. Somatostatin (SST) positive neurons are selectively spared in HD and Quinolinic acid/N-methyl-D-aspartic acid induced excitotoxicity, mimic the model of HD. SST plays neuroprotective role in excitotoxicity and the biological effects of SST are mediated by five somatostatin receptor subtypes (SSTR1-5).To delineate subtype selective biological responses we have here investigated changes in SSTR1 and 5 double knockout mice brain and compared with HD transgenic mouse model (R6/2). Our study revealed significant loss of dopamine and cAMP regulated phosphoprotein of 32 kDa (DARPP-32) and comparable changes in SST, N-methyl-D-aspartic acid receptors subtypes, calbindin and brain nitric oxide synthase expression as well as in key signaling proteins including calpain, phospho-extracellular-signal-regulated kinases1/2, synapsin-IIa, protein kinase C-α and calcineurin in SSTR1/5(-/-) and R6/2 mice. Conversely, the expression of somatostatin receptor subtypes, enkephalin and phosphatidylinositol 3-kinases were strain specific. SSTR1/5 appears to be important in regulating NMDARs, DARPP-32 and signaling molecules in similar fashion as seen in HD transgenic mice.This is the first comprehensive description of disease related changes upon ablation of G- protein coupled receptor gene. Our results indicate that SST and SSTRs might play an important role in regulation of neurodegeneration and targeting this pathway can provide a novel insight in understanding the pathophysiology of Huntington's disease.
url http://europepmc.org/articles/PMC3166321?pdf=render
work_keys_str_mv AT padmeshsrajput somatostatinreceptor1and5doubleknockoutmicemimicneurochemicalchangesofhuntingtonsdiseasetransgenicmice
AT geetanjalikharmate somatostatinreceptor1and5doubleknockoutmicemimicneurochemicalchangesofhuntingtonsdiseasetransgenicmice
AT michaelnorman somatostatinreceptor1and5doubleknockoutmicemimicneurochemicalchangesofhuntingtonsdiseasetransgenicmice
AT shiheliu somatostatinreceptor1and5doubleknockoutmicemimicneurochemicalchangesofhuntingtonsdiseasetransgenicmice
AT bhagavatularsastry somatostatinreceptor1and5doubleknockoutmicemimicneurochemicalchangesofhuntingtonsdiseasetransgenicmice
AT charlesfbrunicardi somatostatinreceptor1and5doubleknockoutmicemimicneurochemicalchangesofhuntingtonsdiseasetransgenicmice
AT ujendrakumar somatostatinreceptor1and5doubleknockoutmicemimicneurochemicalchangesofhuntingtonsdiseasetransgenicmice
_version_ 1725415564435783680